Unknown

Dataset Information

Statins for Primary Prevention in Older Adults-Moving Toward Evidence-Based Decision-Making.


ABSTRACT:

Objectives

To determine the efficacy and safety of statins for primary prevention of atherosclerotic cardiovascular disease (ASCVD) events in older adults, especially those aged 80 and older and with multimorbidity.

Methods

The National Institute on Aging and the National Heart, Lung and Blood Institute convened A multidisciplinary expert panel from July 31 to August 1, 2017, to review existing evidence, identify knowledge gaps, and consider whether statin safety and efficacy data in persons aged 75 and older without ASCVD are sufficient; whether existing data can inform the feasibility, design, and implementation of future statin trials in older adults; and clinical trial options and designs to address knowledge gaps. This article summarizes the presentations and discussion

SUBMITTER: Singh S 

PROVIDER: S-EPMC6741349 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature